JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis: authors' reply

被引：1
|
作者：
Westbrook, R. H. [1 ]
Mufti, G. [1 ]
Heneghan, M. A. [1 ]
机构：
[1] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2011年 / 33卷 / 04期
关键词：
JAK2; HAPLOTYPE; NEOPLASMS;
D O I：
10.1111/j.1365-2036.2010.04546.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：496 / 497
页数：2
相关论文
共 50 条
  • [31] The Study of Thrombosis in JAK2V617F Mutated Myeloproliferative Neoplasms
    Bai, Jie
    Zhang, Yuhui
    Wang, Yingshao
    Teng, Guangshuai
    Wang, Yan
    Du, Chenxiao
    Chen, Yafang
    Zhang, Huiqin
    Li, Yanqi
    Fu, Lixia
    Zhang, Lei
    Zhou, Yuan
    BLOOD, 2019, 134
  • [32] Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
    Mandy N. Lauw
    Erik W. N. Bus
    Alexander F. Y. van Wulfften Palthe
    Michiel Coppens
    Christa H. Homburg
    Saskia Middeldorp
    C. Ellen van der Schoot
    Harry R. Koene
    Bart J. Biemond
    Annals of Hematology, 2012, 91 : 103 - 107
  • [33] Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
    Lauw, Mandy N.
    Bus, Erik W. N.
    Palthe, Alexander F. Y. van Wulfften
    Coppens, Michiel
    Homburg, Christa H.
    Middeldorp, Saskia
    van der Schoot, C. Ellen
    Koene, Harry R.
    Biemond, Bart J.
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 103 - 107
  • [34] JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
    Dentali, F.
    Squizzato, A.
    Appio, L.
    Brivio, L.
    Ageno, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (04) : 722 - 725
  • [35] JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease
    Dentali, F.
    Squizzato, A.
    Appio, L.
    Brivio, L.
    Ageno, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 740 - 740
  • [36] The JAK2V617F tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis
    Goulding, C.
    Uttenthal, B.
    Foroni, L.
    Duke, V.
    Traore, A.
    Kottaridis, P.
    Hoffbrand, A. V.
    Patch, D.
    Mcnamara, C.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (05) : 415 - 419
  • [37] Thrombosis in myeloproliferative disorders: Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F
    Tefferi, Akyalew
    Elliott, Michelle
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (04): : 313 - 320
  • [38] Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis
    Yoo, E. -H.
    Jang, J. -H.
    Park, K. -J.
    Gwak, G. -Y.
    Kim, H. -J.
    Kim, S. -H.
    Kim, D. -K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2011, 33 (05) : 471 - 476
  • [39] Prevalence of the JAK2V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study
    Tondeur, Sylvie
    Boutruche, Sandrine
    Biron-Andreani, Christine
    Schved, Jean-Francois
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (04) : 787 - 789
  • [40] EPIGENETIC CHANGES IN JAK2V617F POSITIVE MYELOPROLIFERATIVE DISORDERS
    Uras, A.
    Fancello, M. A.
    Monne, M.
    Piras, G.
    Palmas, A. D.
    Gaviano, E.
    Noli, A.
    Bianchi, A.
    Gabbas, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 356 - 356
12345